Galmed Pharmaceuticals Ltd(NASDAQ:GLMD) 
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with over...
Website: http://www.galmedpharma.com
Founded: 2000
Full Time Employees: 17
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.40
H 1.42
L 1.28
C 1.34
V 81,892
10EMA 1.34
20EMA 1.34
60EMA 1.34
120EMA 1.34
250EMA 1.34